MedTrace Logo

Evaluation of a Multi-country Medical Oxygen Program

NCT06087315 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2025-06-15

No results posted yet for this study

Summary

REAL-MOXY is a set of 5 mixed methods studies designed to understand how oxygen and pulse oximetry are used (or not used) at a facility level, to identify opportunities and barriers for strengthening oxygen systems for beneficiaries, users and managers.

Conditions

Interventions

OTHER

Multi-faceted oxygen systems strengthening interventions (different for each country)

The specific approaches are different in each country but broadly include efforts to: (1) strengthening policies, strategies, and governance of medical oxygen production, distribution, maintenance, and use; (2) building capacity of healthcare workers and technicians to use and maintain oxygen well, and (3) strengthening oxygen-related data acquisition and use for forecasting, budgeting, and monitoring.

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • University of Health Sciences Lao PDR

    collaborator UNKNOWN

  • University of Health Sciences, Cambodia

    collaborator UNKNOWN

  • Clinton Health Access Initiative, Nigeria

    collaborator OTHER

  • Clinical and Public Health Services at Ministry of Health Rwanda

    collaborator UNKNOWN

  • University of Ibadan

    collaborator OTHER

  • Karolinska Institutet

    collaborator OTHER

  • Murdoch Childrens Research Institute

    lead OTHER

Principal Investigators

  • Hamish Graham, PhD · Murdoch Childrens Research Institute

  • Carina King, PhD · Karolinska Institutet

Eligibility

Min Age
0 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-27
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Cambodia
  • Nigeria
  • Uganda

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06087315 on ClinicalTrials.gov